作者:Kumar, Sandeep、Mitra, Rangan、Ayyannan, Senthil Raja
DOI:10.1007/s00044-024-03304-1
日期:——
clorgyline (MAO-A IC50 = 0.096 ± 0.003 µM) and selegyline (MAO B IC50 = 0.021 ± 0.002 µM). Further, the 2,4-dichloro analog (compound 20) emerged as a potent dual MAO (MAO-A IC50 = 0.160 ± 0.009 µM, MAO-B IC50 = 0.071 ± 0.002 µM) and ChE (AChE IC50 = 2.611 ± 0.086 µM and BChE IC50 = 4.22 ± 0.162 µM) inhibitor. Moreover, molecular simulation studies revealed that H-bonding and hydrophobic interactions stabilize
设计、合成了一组芝麻酚衍生的乙酰胺,并针对单胺氧化酶(MAO-A 和 MAO-B)和胆碱酯酶(AChE 和 BChE)进行了评估,用于治疗神经退行性疾病。大多数测试化合物在微摩尔至纳摩尔范围内表现出抑制活性。 3,4-二氯衍生物(化合物19 )是最有效的 MAO-A 抑制剂(IC 50 = 0.053 ± 0.001 µM),而 4-甲基类似物(化合物16 )则成为主要的 MAO-B 抑制剂(IC 50 = 0.019 ± 0.001 µM) 与参考抑制剂氯吉兰 (MAO-A IC 50 = 0.096 ± 0.003 µM) 和司来吉兰 (MAO B IC 50 = 0.021 ± 0.002 µM) 相比。此外,2,4-二氯类似物(化合物20 )作为有效的双 MAO(MAO-A IC 50 = 0.160 ± 0.009 µM,MAO-B IC 50 = 0.071 ± 0.002 µM)和